Medtronic (MDT)
(Delayed Data from NYSE)
$81.04 USD
-0.62 (-0.76%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $81.04 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Medtronic PLC [MDT]
Reports for Purchase
Showing records 301 - 320 ( 504 total )
Company: Medtronic PLC
Industry: Medical - Products
Not The Best Nor The Worst of MDT''s Quarters; Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
Medical Devices: 2Q16 MedTech Preview: Stable Trends and Healthy Underlying Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Industry Report ; MEDTECH; This report contains brief updates on the following: MDT, JNJ, EW. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: ZACKS INVESTMENT RESEARCH
Company: Medtronic PLC
Industry: Medical - Products
Diabetes: Artificial Pancreas Workshop Provides Insights On the Future of the Diabetes Market
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
Innovation and Globalization Highlights From Analyst Meeting; Maintain NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Diabetes Technology Update: Regulatory Environment for AP Programs Less Onerous; MDT''s 670G and CGM Technology Improve; DXCM Seeks Replacement Claim
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
FY4Q16 Review: Adjustments Obscure Operating/EPS Leverage Potential; Maintain Neutral; PT to $82
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
FY4Q16 Preview: Expecting an In Line Quarter Followed By Tougher Comps Ahead; Maintain Neutral
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
J-J Medical Devices Investor Day Takeaways on Robotic Surgery, Diabetes, AFib,Sinus Surgery, Endoscopic Stapling
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
MDT/UHC Insulin Pump Agreement Could Become A Significant POSITIVE for the Other
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Volatility in Diabetes Stocks Following UNH/MDT Agreement Creates Buying Opportunity; Reiterate OUTPERFORM on DXCM, PODD, TNDM
Provider: WEDBUSH SECURITIES INC.
Company: Medtronic PLC
Industry: Medical - Products
Company: Medtronic PLC
Industry: Medical - Products
Diabetes 1Q16 Earnings Preview: Despite Seasonally Soft 1Q, Expecting Healthy Trends Driven By New Product Launches
Provider: WEDBUSH SECURITIES INC.